Babylat AG

On-site human milk fortifiers for preterm neonates in NICUs

Very low birth weight (VLBW) preterm infants (<1.5 kg) require up to four times more protein and energy than human milk alone provides. Without adequate fortification, they face poor weight gain and lifelong neurodevelopmental disorders. About 1.5–2% of all newborns fall into this category and need protein-enriched nutrition daily for 2–3 months.
We are developing the BABYLAT Enricher—a novel, automated device that enables hospitals to concentrate the protein and fat fraction from human milk (mother own milk or donor milk) directly on-site. Our proprietary bedside technology allows fast, efficient extraction of human milk protein. No comparable automated solution currently exists on the market. We plan to sell the device and daily filter consumables to large perinatal centers with NICUs.

Only registered users have access to funding information.
Please log in or register to continue. Registration is free.

No Jobs

Documents

Venture Kick

Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.

Website

Venture Leaders Medtech

Babylat AG

On-site human milk fortifiers for preterm neonates in NICUs

Headquarter:
Bern

Foundation Date:
October 2020

Technology:

  • Medtech

Sectors:

  • Instruments
  • Hardware
  • Healthcare infrastructure
  • Medical devices

Support received

  • Support venture leaders
  • Support venturekick